Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 1;85(3):296-300.
doi: 10.1292/jvms.22-0416. Epub 2023 Jan 17.

Distribution of enrofloxacin within the bronchoalveolar region of healthy pigs

Affiliations

Distribution of enrofloxacin within the bronchoalveolar region of healthy pigs

Moe Ijiri et al. J Vet Med Sci. .

Abstract

This study aimed to elucidate the distribution of enrofloxacin (ERFX) within the bronchoalveolar region of pigs. Six clinically healthy pigs were allocated to intramuscular treatments with either a single dose of 5 mg/kg or 7.5 mg/kg ERFX. Samples of plasma and bronchoalveolar lavage fluid (BALF) were obtained from each pig 0 (before administration), 3, 8, and 24 hr after ERFX administration. The ERFX concentrations in pulmonary epithelial lining fluid (ELF) and BALF cells showed a similar pattern during the experimental period, whereby ERFX concentrations in both ELF and BALF cells were higher than those in the plasma. These results suggest that intramuscularly injected ERFX is well-distributed in the bronchoalveolar region.

Keywords: bronchoalveolar lavage fluid; distribution; enrofloxacin; pig.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare. This study was supported by grants from the Bayer Yakuhin Ltd (Elanco Japan K.K.).

Figures

Fig. 1.
Fig. 1.
Concentration of enrofloxacin determined within plasma, pulmonary epithelial lining fluid (ELF), and cells in bronchoalveolar lavage fluid (BALF cells) after intramuscular injection for pigs. (A) Baytril 10% injectable solution (Dose: 5 mg/kg) (B) Baytril 1ject (Dose: 7.5 mg/kg). Data are shown as mean ± SD. Values with different letters indicate significant differences between regions at the same sampling time (P<0.05).

Similar articles

Cited by

References

    1. Ahmad SU, Sun J, Cheng F, Li B, Arbab S, Zhou X, Zhang J. 2021. Comparative study on pharmacokinetics of four long-acting injectable formulations of enrofloxacin in pigs. Front Vet Sci 7: 604628. doi: 10.3389/fvets.2020.604628 - DOI - PMC - PubMed
    1. AliAbadi FS, Lees P. 2000. Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation. Int J Antimicrob Agents 14: 307–313. doi: 10.1016/S0924-8579(00)00142-4 - DOI - PubMed
    1. Bimazubute M, Cambier C, Baert K, Vanbelle S, Chiap P, Albert A, Delporte JP, Gustin P. 2010. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. J Vet Pharmacol Ther 33: 183–188. doi: 10.1111/j.1365-2885.2009.01123.x - DOI - PubMed
    1. Blondeau JM, Fitch SD. 2019. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis. PLoS One 14: e0210154. doi: 10.1371/journal.pone.0210154 - DOI - PMC - PubMed
    1. Boothe HW, Jones SA, Wilkie WS, Boeckh A, Stenstrom KK, Boothe DM. 2005. Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogs. Am J Vet Res 66: 1770–1774. doi: 10.2460/ajvr.2005.66.1770 - DOI - PubMed